Clear cell carcinoma of the ovary: A study of 59 cases

Mark A. Crozier, Larry J. Copeland, Elvio G. Silva, David M. Gershenson, C. Allen Stringer

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Clear cell carcinoma of the ovary accounts for 2 to 3% of all epithelial ovarian neoplasms. Patient profiles, pathological characteristics, and results of treatment are reviewed for 59 patients. The median age was 51. Disease extent at diagnosis was as follows: stage I, 18 patients (31%); stage II, 20 patients (34%); stage III, 15 patients (25%); stage IV, 3 patients (5%); and unknown stage, 3 patients (5%). Endometriosis was identified in 13 patients (22%). Hysterectomy and bilateral salpingo-oophorectomy were performed in 47 patients (80%), unilateral salpingo-oophorectomy in 8 patients (14%), and bilateral salpingo-oophorectomy in 4 patients (7%). Radiotherapy was given to 15 patients (25%), and chemotherapy was given to 42 patients (71%). The overall 2- and 5-year survival rates were 49 and 43%. The median survival was 26 months. Patients with tumors with fewer than 10 mitoses per 10 high-power fields and less than 50% solid areas had significantly longer disease-free intervals. Clear cell tumors are usually diagnosed at an earlier disease stage than the other epithelial ovarian cancers; stage for stage, however, the prognoses are similar.

Original languageEnglish (US)
Pages (from-to)199-203
Number of pages5
JournalGynecologic Oncology
Volume35
Issue number2
DOIs
StatePublished - 1989

Fingerprint

Ovary
Carcinoma
Ovariectomy
Glandular and Epithelial Neoplasms
Endometriosis
Hysterectomy
Mitosis
Ovarian Neoplasms
Neoplasms
Radiotherapy
Survival Rate
Drug Therapy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Crozier, M. A., Copeland, L. J., Silva, E. G., Gershenson, D. M., & Stringer, C. A. (1989). Clear cell carcinoma of the ovary: A study of 59 cases. Gynecologic Oncology, 35(2), 199-203. https://doi.org/10.1016/0090-8258(89)90043-7

Clear cell carcinoma of the ovary : A study of 59 cases. / Crozier, Mark A.; Copeland, Larry J.; Silva, Elvio G.; Gershenson, David M.; Stringer, C. Allen.

In: Gynecologic Oncology, Vol. 35, No. 2, 1989, p. 199-203.

Research output: Contribution to journalArticle

Crozier, MA, Copeland, LJ, Silva, EG, Gershenson, DM & Stringer, CA 1989, 'Clear cell carcinoma of the ovary: A study of 59 cases', Gynecologic Oncology, vol. 35, no. 2, pp. 199-203. https://doi.org/10.1016/0090-8258(89)90043-7
Crozier MA, Copeland LJ, Silva EG, Gershenson DM, Stringer CA. Clear cell carcinoma of the ovary: A study of 59 cases. Gynecologic Oncology. 1989;35(2):199-203. https://doi.org/10.1016/0090-8258(89)90043-7
Crozier, Mark A. ; Copeland, Larry J. ; Silva, Elvio G. ; Gershenson, David M. ; Stringer, C. Allen. / Clear cell carcinoma of the ovary : A study of 59 cases. In: Gynecologic Oncology. 1989 ; Vol. 35, No. 2. pp. 199-203.
@article{329889cf1e0142f580d7415e885e700c,
title = "Clear cell carcinoma of the ovary: A study of 59 cases",
abstract = "Clear cell carcinoma of the ovary accounts for 2 to 3{\%} of all epithelial ovarian neoplasms. Patient profiles, pathological characteristics, and results of treatment are reviewed for 59 patients. The median age was 51. Disease extent at diagnosis was as follows: stage I, 18 patients (31{\%}); stage II, 20 patients (34{\%}); stage III, 15 patients (25{\%}); stage IV, 3 patients (5{\%}); and unknown stage, 3 patients (5{\%}). Endometriosis was identified in 13 patients (22{\%}). Hysterectomy and bilateral salpingo-oophorectomy were performed in 47 patients (80{\%}), unilateral salpingo-oophorectomy in 8 patients (14{\%}), and bilateral salpingo-oophorectomy in 4 patients (7{\%}). Radiotherapy was given to 15 patients (25{\%}), and chemotherapy was given to 42 patients (71{\%}). The overall 2- and 5-year survival rates were 49 and 43{\%}. The median survival was 26 months. Patients with tumors with fewer than 10 mitoses per 10 high-power fields and less than 50{\%} solid areas had significantly longer disease-free intervals. Clear cell tumors are usually diagnosed at an earlier disease stage than the other epithelial ovarian cancers; stage for stage, however, the prognoses are similar.",
author = "Crozier, {Mark A.} and Copeland, {Larry J.} and Silva, {Elvio G.} and Gershenson, {David M.} and Stringer, {C. Allen}",
year = "1989",
doi = "10.1016/0090-8258(89)90043-7",
language = "English (US)",
volume = "35",
pages = "199--203",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Clear cell carcinoma of the ovary

T2 - A study of 59 cases

AU - Crozier, Mark A.

AU - Copeland, Larry J.

AU - Silva, Elvio G.

AU - Gershenson, David M.

AU - Stringer, C. Allen

PY - 1989

Y1 - 1989

N2 - Clear cell carcinoma of the ovary accounts for 2 to 3% of all epithelial ovarian neoplasms. Patient profiles, pathological characteristics, and results of treatment are reviewed for 59 patients. The median age was 51. Disease extent at diagnosis was as follows: stage I, 18 patients (31%); stage II, 20 patients (34%); stage III, 15 patients (25%); stage IV, 3 patients (5%); and unknown stage, 3 patients (5%). Endometriosis was identified in 13 patients (22%). Hysterectomy and bilateral salpingo-oophorectomy were performed in 47 patients (80%), unilateral salpingo-oophorectomy in 8 patients (14%), and bilateral salpingo-oophorectomy in 4 patients (7%). Radiotherapy was given to 15 patients (25%), and chemotherapy was given to 42 patients (71%). The overall 2- and 5-year survival rates were 49 and 43%. The median survival was 26 months. Patients with tumors with fewer than 10 mitoses per 10 high-power fields and less than 50% solid areas had significantly longer disease-free intervals. Clear cell tumors are usually diagnosed at an earlier disease stage than the other epithelial ovarian cancers; stage for stage, however, the prognoses are similar.

AB - Clear cell carcinoma of the ovary accounts for 2 to 3% of all epithelial ovarian neoplasms. Patient profiles, pathological characteristics, and results of treatment are reviewed for 59 patients. The median age was 51. Disease extent at diagnosis was as follows: stage I, 18 patients (31%); stage II, 20 patients (34%); stage III, 15 patients (25%); stage IV, 3 patients (5%); and unknown stage, 3 patients (5%). Endometriosis was identified in 13 patients (22%). Hysterectomy and bilateral salpingo-oophorectomy were performed in 47 patients (80%), unilateral salpingo-oophorectomy in 8 patients (14%), and bilateral salpingo-oophorectomy in 4 patients (7%). Radiotherapy was given to 15 patients (25%), and chemotherapy was given to 42 patients (71%). The overall 2- and 5-year survival rates were 49 and 43%. The median survival was 26 months. Patients with tumors with fewer than 10 mitoses per 10 high-power fields and less than 50% solid areas had significantly longer disease-free intervals. Clear cell tumors are usually diagnosed at an earlier disease stage than the other epithelial ovarian cancers; stage for stage, however, the prognoses are similar.

UR - http://www.scopus.com/inward/record.url?scp=0024416245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024416245&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(89)90043-7

DO - 10.1016/0090-8258(89)90043-7

M3 - Article

C2 - 2807010

AN - SCOPUS:0024416245

VL - 35

SP - 199

EP - 203

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -